Stock Taper 
Clover Health Investments, Corp., founded in 2014 and based in Franklin, Tennessee, is a Medicare Advantage insurer offering PPO and HMO plans via its Clover Assistant platform, with additional focus on non-insurance businesses.
Clover Assistant is a web-based AI-powered clinical decision support tool that offers real-time, personalized patient recommendations to improve outcomes, available as SaaS to payers and providers under the name Counterpart Assistant.
In its third-quarter 2025 earnings report on November 4, 2025, Clover Health announced a 35% year-over-year increase in Medicare Advantage membership and a 50% rise in total revenues. However, the company reported a GAAP net loss of $24.4 million and significantly reduced its full-year Adjusted EBITDA guidance, causing a negative reaction from investors and a notable drop in the stock price. [7, 12]
Clover Health initiated a strategic partnership with IPC Digital Health to launch a new community pharmacy pilot program in New Jersey. The program utilizes Clover's AI-powered Clover Assistant platform to help Medicare Advantage members better manage their medications in collaboration with local pharmacists, aiming to improve health outcomes and reduce hospitalizations.
A $0 monthly premium sounds like free coverage until you read the pages most people skip. One number buried in the Annual Notice of Change quietly decides how much a serious diagnosis will actually cost in 2027.
WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, November 4, 2026.
WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its 2027 Medicare Advantage (MA) plan offerings, with a continued focus on PPO choice, affordable access to preventive care and meaningful member value.
Overall rating: D+
| PEER | PRICE | |
|---|---|---|
 CVS | $88.15 | COMPARE |
 CI | $280.25 | COMPARE |
 HUM | $386.54 | COMPARE |
 CNC | $64.63 | COMPARE |
 TWST | $173.59 | COMPARE |
 TXG | $83.23 | COMPARE |
 OSCR | $32.94 | COMPARE |
 LFST | $12.07 | COMPARE |
